Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News Australia’s Talon Energy to exit from UK North Sea exploration Talon Energy said that it has decided to launch an exit of its portfolio of exploration assets in… byPallavi MadhirajuFebruary 13, 2022
